Loren Data Corp.

'

 
 

COMMERCE BUSINESS DAILY ISSUE OF FEBRUARY 1,2000 PSA#2527

National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Natcher Building, Room 5AS-13A, 45 Center Drive, MSC 6500, Bethesda, Maryland 20892-6500

A -- STUDY OF THE EFFICACY OF GLUCOSAMINE AND GLUCOSAMINE/CHONDROITIN SULFATE IN KNEE OSTEOARTHRITIS SOL RFP NIH-NIAMS-00-002 POC Eileen Webster-Cissel, 301-594-2543 E-MAIL: Click here to contact the contracting officer via, ew52c@nih.gov. The National Center for Complementary and Alternative Medicine (NCCAM) intends to negotiate on a sole source basis with the University of Utah, Salt Lake City, Utah, for additional work related to an existing research and development contract for a "Study of the Efficacy of Glucosamine and Glucosamine/Chondroitin Sulfate in Knee Osteoarthritis." It is proposed that an active control arm be added to the study. This would entail an estimated additional 400 patients be enrolled in this clinical trial. The Government has determined that the University of Utah is the only source capable of providing the additional work. A determination to use other than full and open competition has been made in accordance with 41 U.S.C. 253(c)(1) as set forth in FAR 6.302-1. Inherent duplication of cost to the Government and unacceptable delays in obtaining this support make competition of this requirement not feasible. All responsible sources may submit a proposal which will be considered by the Government. A determination not to compete the proposed work based upon responses to this notice is solely within the discretion of the Contracting Officer. This notice of intent is not an announcement of the availability of a Request for Proposals (RFP), nor is a RFP available. See Numbered Note 22. Posted 01/28/00 (W-SN419818). (0028)

Loren Data Corp. http://www.ld.com (SYN# 0004 20000201\A-0004.SOL)


A - Research and Development Index Page